Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal β-carbonic anhydrase from Candida albicans with sulfonamides

被引:51
|
作者
Innocenti, Alessio [1 ]
Hall, Rebecca A. [2 ]
Schlicker, Christine [3 ]
Scozzafava, Andrea [1 ]
Steegborn, Clemens [3 ]
Muehlschlegel, Fritz A. [2 ]
Supuran, Claudiu T. [1 ]
机构
[1] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
[2] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England
[3] Ruhr Univ Bochum, Dept Phys Chem, D-44801 Bochum, Germany
关键词
Carbonic anhydrase; beta-Class enzymes; Nce103; Can2; Candida albicans; Cryptococcus neoformans; Sulfonamide; YEAST SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; CLASS ENZYMES; ISOFORM-IX; CAN2; CO2;
D O I
10.1016/j.bmc.2009.05.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The beta-carbonic anhydrase (CA, EC 4.2.1.1) from the fungal pathogen Candida albicans (Nce103) is involved in a CO2 sensing pathway critical for the pathogen life cycle and amenable to drug design studies. Herein we report an inhibition study of Nce103 with a library of sulfonamides and one sulfamate, showing that Nce103, similarly to the related enzyme from Cryptococcus neoformans Can2, is inhibited by these compounds with K(I)s in the range of 132 nM-7.6 mu M. The best Nce103 inhibitors were acetazolamide, methazolamide, bromosulfanilamide, and 4-hydroxymethylbenzenesulfonamide (K(I)s < 500 nM). A homology model was generated for Nce103 based on the crystal structure of Can2. The model shows that compounds with zinc-binding groups incorporating less polar moieties and compact scaffolds generate stronger Nce103 inhibitors, whereas highly polar zinc-binding groups and bulkier compounds appear more promising for the specific inhibition of Can2. Such compounds may be useful for the design of antifungal agents possessing a new mechanism of action. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4503 / 4509
页数:7
相关论文
共 50 条
  • [1] Carbonic anhydrase inhibitors. Inhibition of the fungal β-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids
    Innocenti, Alessio
    Winum, Jean-Yves
    Hall, Rebecca A.
    Muehlschlegel, Fritz A.
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (10) : 2642 - 2645
  • [2] Carbonic anhydrase inhibitors. The β-carbonic anhydrases from the fungal pathogens Cryptococcus neoformans and Candida albicans are strongly inhibited by substituted-phenyl-1H-indole-5-sulfonamides
    Guzel, Ozlen
    Maresca, Alfonso
    Hall, Rebecca A.
    Scozzafava, Andrea
    Mastrolorenzo, Antonio
    Muhlschlegel, Fritz A.
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2508 - 2511
  • [3] Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with aliphatic and aromatic carboxylates
    Innocenti, Alessio
    Hall, Rebecca A.
    Schlicker, Christine
    Muehlschlegel, Fritz A.
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (07) : 2654 - 2657
  • [4] Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives
    Carta, Fabrizio
    Innocenti, Alessio
    Hall, Rebecca A.
    Muehlschlegel, Fritz A.
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) : 2521 - 2526
  • [5] Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides
    Bertucci, Anthony
    Innocenti, Alessio
    Zoccola, Didier
    Scozzafava, Andrea
    Tambutte, Sylvie
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (14) : 5054 - 5058
  • [6] Carbonic Anhydrase Inhibitors. Cloning, Characterization, and Inhibition Studies of a New β-Carbonic Anhydrase from Mycobacterium tuberculosis
    Nishimori, Isao
    Minakuchi, Tomoko
    Vullo, Daniela
    Scozzafava, Andrea
    Innocenti, Alessio
    Supuran, Claudiu T.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) : 3116 - 3120
  • [7] Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c
    Carta, Fabrizio
    Maresca, Alfonso
    Covarrubias, Adrian Suarez
    Mowbray, Sherry L.
    Jones, T. Alwyn
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (23) : 6649 - 6654
  • [8] Carbonic anhydrase inhibitors. Inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with anions
    Innocenti, Alessio
    Leewattanapasuk, Worraanong
    Muehlschlegel, Fritz A.
    Mastrolorenzo, Antonio
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4802 - 4805
  • [9] Carbonic anhydrase inhibitors: Inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides
    Vullo, Daniela
    Leewattanapasuk, Worraanong
    Muehlschlegel, Fritz A.
    Mastrolorenzo, Antonio
    Capasso, Clemente
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) : 2647 - 2652
  • [10] Carbonic anhydrase inhibitors.: Inhibition of red blood cell ostrich (Struthio camelus) carbonic anhydrase with a series of aromatic and heterocyclic sulfonamides
    Özensoy, Ö
    Isik, S
    Arslan, O
    Arslan, M
    Scozzafava, A
    Supuran, CT
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2005, 20 (04) : 383 - 387